Početna › Glioblastom › Florida
Kliničke studije za Glioblastom u državi Florida
30 studija za Glioblastom traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- Baptist Health Herbert Wertheim Cancer Institute, Miami
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06991101Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- Mayo Clinic in Florida, Jacksonville
- i još 2
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT05432804A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Sylvester Comprehensive Cancer Center*, Miami
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT03970447The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07285044Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Mayo Clinic of Jacksonville Florida, Jacksonville
- Miami Cancer Institute, Miami
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT05902169Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Miami Cancer Institute, Miami
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07326566A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Mayo Jacksonville, Jacksonville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05303467Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Advent Health, Orlando
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07195591Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06047379RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
- UF Health, Gainesville
U tijeku regrutacijaFaza 1
Od 18 do 80 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT06389591OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
- UF Health Shands Hospital, Gainesville
U tijeku regrutacijaFaza 2
Od 18 do 90 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT06558214A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona, Orlando
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT06914128Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
- University of Miami (Data collection only), Miami
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06934889Targeted Pediatric High-Grade Glioma Therapy
- University of Miami, Miami
U tijeku regrutacijaOpažajna studija
12 Months – 39 Years · Oba spola · Ažurirano 8. ruj 2026. · NCT05839379Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- i još 6
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. ruj 2026. · NCT06860594Study of Olutasidenib and Temozolomide in HGG
- University of Miami Hospital and Clinics, Miami
U tijeku regrutacijaFaza 2
Od 12 do 39 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Florida Health, Gainesville
- Mayo Clinic - Florida, Jacksonville
- University of Miami Health, Miami
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT05303519Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
- Baptist MD Anderson Cancer Center, Jacksonville
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT06319027Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- Mayo Clinic in Florida, Jacksonville
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT07091864A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Mayo Clinic in Florida, Jacksonville
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. kol 2026. · NCT07074756A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Moffitt Cancer Center, Tampa
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. srp 2026. · NCT07464925Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
- University of Miami, Miami
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 29. srp 2026. · NCT05284643DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- Baptist MD Anderson Cancer Center, Jacksonville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. srp 2026. · NCT06805305A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- UF Health, Gainesville
U tijeku regrutacijaFaza 1
Od 4 godina i više · Oba spola · Ažurirano 25. lip 2026. · NCT04573140A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Mayo Clinic Hospital, Jacksonville
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 14. tra 2026. · NCT07185880Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Jacksonville, Jacksonville
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 13. tra 2026. · NCT06810544Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
- Mayo Clinic in Florida, Jacksonville
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. tra 2026. · NCT05789394Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
- Miami Cancer Institute at Baptist Health, Inc., Miami
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 4. velj 2026. · NCT05756985Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
- Jackson Memorial Hospital, Miami
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 1 do 21 godina · Oba spola · Ažurirano 8. pro 2025. · NCT05956821SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.